ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,173,000 | -29.9% | 29,029 | -0.1% | 0.01% | -28.6% |
| Q2 2015 | $1,673,000 | -1.5% | 29,070 | +8.9% | 0.01% | 0.0% |
| Q1 2015 | $1,699,000 | +3.1% | 26,688 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $1,648,000 | +39.5% | 26,688 | -12.3% | 0.01% | +40.0% |
| Q3 2014 | $1,181,000 | +3.9% | 30,416 | -7.8% | 0.01% | 0.0% |
| Q2 2014 | $1,137,000 | -20.3% | 33,004 | 0.0% | 0.01% | -16.7% |
| Q1 2014 | $1,426,000 | +8.4% | 33,004 | 0.0% | 0.01% | +9.1% |
| Q4 2013 | $1,315,000 | +6.1% | 33,004 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $1,239,000 | +39.7% | 33,004 | 0.0% | 0.01% | +37.5% |
| Q2 2013 | $887,000 | – | 33,004 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
| DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
| WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
| Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
| SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
| Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
| PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
| Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
| PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |